Google
Trusted Resources: News & Events
Latest announcements and gatherings
MARAC Advisory Statement: Update About COVID-19
December 23, 2021 – The Sickle Cell Disease Association of America’s Medical and Research Advisory Committee reminds the sickle cell community that the COVID-19 pandemic is having another increase in infections. New variants like omicron are emerging, as are common for RNA viruses, and vaccination rates need to consequently improve. Vaccinations can protect against severe illness. A new medication might also help as early treatment for infected individuals.
MARAC Recommendations
• No general recommendation for all individuals with SCD to stay home nor for all to return to in-person activities. Patients and families need to make individualized assessments of the risks and trade-offs of returning to work or school in person. Factors to consider include vaccination status, the rate of COVID-19 and variants in your community, family socioeconomic situation, protective measures in the building (proper ventilation, physical distancing, etc.), mental health needs and educational needs.
+myBinderRelated Content
-
Sickle Cell Partners of the CarolinasSickle Cell Partners of the Carolinas wa...
-
Warrior U Social Media Series: Sickle Cell Community ConsortiumSocial Media As A Tool for CBO Communit...
-
Perspectives and practices of athletic trainers and team physicians implementing the 2010 NCAA sickle cell trait scr...Sickle cell trait (SCT) is usually benig...
-
Q & A With Andre Marcel HarrisQ: When were you diagnosed with sickle c...
-
Sickle Cell Disease Association of North TexasSickle Cell Disease Association of North...
-
U.S. Government Awards Missouri Researcher $4.3 Million to Study Sickle Cell in Teens, AdultsThe National Institutes of Health (NIH) ...
-
Ep. 30 Jordin Jackson ConversationMiracle kid Jordin Jackson speaks to liv...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.